| __timestamp | Insmed Incorporated | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 31073000 | 22570000 |
| Thursday, January 1, 2015 | 43216000 | 24378000 |
| Friday, January 1, 2016 | 50679000 | 26621000 |
| Sunday, January 1, 2017 | 79171000 | 28653000 |
| Monday, January 1, 2018 | 168218000 | 37734000 |
| Tuesday, January 1, 2019 | 210796000 | 41884000 |
| Wednesday, January 1, 2020 | 203613000 | 64435000 |
| Friday, January 1, 2021 | 234273000 | 57483000 |
| Saturday, January 1, 2022 | 265784000 | 70062000 |
| Sunday, January 1, 2023 | 344501000 | 52790000 |
Infusing magic into the data realm
In the competitive landscape of biotechnology, understanding spending patterns is crucial. Over the past decade, Insmed Incorporated has consistently outpaced Ligand Pharmaceuticals in Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Insmed's SG&A expenses surged by over 1,000%, peaking at approximately $345 million in 2023. In contrast, Ligand's growth was more modest, with a 133% increase, reaching around $70 million in 2022. This disparity highlights Insmed's aggressive investment strategy, possibly reflecting its focus on expanding market presence and operational capabilities. Meanwhile, Ligand's steadier growth suggests a more conservative approach, potentially prioritizing efficiency and cost management. These spending patterns offer a window into each company's strategic priorities and market positioning, providing valuable insights for investors and industry analysts alike.
Breaking Down SG&A Expenses: BeiGene, Ltd. vs Insmed Incorporated
Insmed Incorporated vs Walgreens Boots Alliance, Inc.: SG&A Expense Trends
Insmed Incorporated and Blueprint Medicines Corporation: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Insmed Incorporated vs Ultragenyx Pharmaceutical Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Insmed Incorporated and Geron Corporation
Dr. Reddy's Laboratories Limited and Ligand Pharmaceuticals Incorporated: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Walgreens Boots Alliance, Inc. vs Ligand Pharmaceuticals Incorporated Trends and Insights
Cost Management Insights: SG&A Expenses for Opthea Limited and Ligand Pharmaceuticals Incorporated
PTC Therapeutics, Inc. or Ligand Pharmaceuticals Incorporated: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Ligand Pharmaceuticals Incorporated or Amphastar Pharmaceuticals, Inc.
Selling, General, and Administrative Costs: Ligand Pharmaceuticals Incorporated vs Travere Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Ligand Pharmaceuticals Incorporated and MiMedx Group, Inc.